ArticleInternational journal of general medicine2025
A Study of the Correlation Between the Inflammatory Index and Disease Activity in Ulcerative Colitis.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Diagnostic efficacy of pan-immune inflammation value for ulcerative colitis activity: a study based on multi-indicator comparison and diagnostic grey zone validation.BMC gastroenterology · 2026Article
- Inflammatory, Nutritional, and Atherogenic Profiles Associated with Histologic Activity in Inflammatory Bowel Disease.Biomedicines · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To analyze the level of systemic immune-inflammatory index (SII) in patients with ulcerative colitis (UC) and assess its relationship with disease activity. Methods: This study included 616 UC patients and 211 healthy controls. Disease activity was assessed using the modified Mayo score, categorizing patients into remission (n=115) and active (n=501) groups, with the latter further stratified into mild, moderate, and severe activity. We compared multiple inflammatory indices-including SII, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), neutrophil percentage-albumin ratio (NPAR), and others-between groups. Spearman correlation and ROC curve analyses were used to evaluate their associations with disease activity and predictive value for active and severe UC. Results: SII, NLR, PLR, NPAR, and several other indices were significantly higher in the UC group than controls, while lymphocyte-to-monocyte ratio (LMR) and LHR were lower (all P<0.05). Most indices were also elevated in active versus remission UC (P<0.05), and showed significant differences across severity subgroups (P<0.05), with SII, NLR, NPAR, NHR, and MHR increasing with severity. Spearman analysis revealed positive correlations between these markers and disease activity/severity (P<0.001). ROC analysis demonstrated significant predictive value for active and severe UC (AUC>0.60, P<0.001), with NPAR exhibiting the highest efficacy (AUC=0.854). Conclusion: SII, NLR, PLR, NPAR, and other inflammatory indices are useful non-invasive biomarkers for assessing UC disease activity and severity, with NPAR showing the strongest predictive performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.